このエントリーをはてなブックマークに追加


ID 69496
FullText URL
Author
Nakanoh, Hiroyuki Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
Tsuji, Kenji Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University ORCID Kaken ID researchmap
Fukushima, Kazuhiko Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
Uchida, Naruhiko Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
Haraguchi, Soichiro Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
Kitamura, Shinji Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University Kaken ID publons
Wada, Jun Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University ORCID Kaken ID publons researchmap
Abstract
Kidney organoids, derived from stem cells, including pluripotent stem cells and adult progenitor cells, have been reported as three-dimensional in vitro models that reflect key aspects of kidney development, structure, and function. Advances in differentiation protocols and tissue engineering have enabled the generation of organoids that exhibit nephron-like structures, including glomerular and tubular structures. Kidney organoids have been widely applied in several directions, including disease modeling and therapeutic screening, drug nephrotoxicity evaluation, and regenerative medicine. In particular, kidney organoids offer a promising platform for studying genetic kidney diseases, such as polycystic kidney disease and congenital anomalies of the kidney and urinary tract (CAKUT), by allowing patient-specific modeling for the analysis of pathophysiology and therapeutic screening. Despite several current limitations, such as incomplete maturation, lack of full nephron segmentation, and variability between protocols and cell conditions, further technological innovations such as microfluidics and bioengineering may refine kidney organoid systems. This review highlights recent advances in kidney organoid research, outlines major applications, and discusses future directions to enhance their physiological relevance, functional maturity, and translational integration into preclinical and clinical nephrology.
Keywords
kidney organoid
stem cell
disease modeling
drug toxicity
drug screening
regenerative medicine
Published Date
2025-10-29
Publication Title
Life
Volume
volume15
Issue
issue11
Publisher
MDPI AG
Start Page
1680
ISSN
2075-1729
Content Type
Journal Article
language
English
OAI-PMH Set
岡山大学
Copyright Holders
© 2025 by the authors.
File Version
publisher
DOI
Related Url
isVersionOf https://doi.org/10.3390/life15111680
License
https://creativecommons.org/licenses/by/4.0/
Citation
Nakanoh, H.; Tsuji, K.; Fukushima, K.; Uchida, N.; Haraguchi, S.; Kitamura, S.; Wada, J. Kidney Organoids: Current Advances and Applications. Life 2025, 15, 1680. https://doi.org/10.3390/life15111680
助成情報
( ウエスコ学術振興財団 / Wesco Scientific Promotion Foundation )
24K11411: 腎臓線維化におけるSemaphorin3A経路の病態機序の解明と治療への応用 ( 独立行政法人日本学術振興会 / Japan Society for the Promotion of Science )